Physician profile
Veronica Kwiatkowski
NPI 1730633090
$1,035.55
in general payments reported to CMS, 2019-2025
8 companies · $73.62 in 2025
The $73.62 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $187 · 2022: $395 · 2023: $379 · 2025: $73.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $369.48 | 2021-2023 | |
| Genzyme Corporation | $256.69 | 2021-2025 | |
| Genentech, INC. | $118.16 | 2023 | Xolair |
| Glaxosmithkline, LLC. | $107.10 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $63.11 | 2022-2023 | Dupixent |
| Csl Behring | $49.61 | 2025 | Hizentra |
| Genentech USA, INC. | $39.93 | 2022 | |
| Amgen INC. | $31.47 | 2023 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Kwiatkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.